SG
BMY icon

StoneX Group’s Bristol-Myers Squibb BMY Stock Holding History

StoneX Group’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$358K Sell
5,915
-4,548
-43% -$265K 0.02% 512
2025
Q4 		$565K Buy
10,463
+683
+7% +$32.9K 0.02% 499
2025
Q3 		$441K Sell
9,780
-2,358
-19% -$110K 0.02% 579
2025
Q2 		$562K Sell
12,138
-4,377
-27% -$215K 0.03% 461
2025
Q1 		$1.01M Buy
16,515
+1,646
+11% +$95.9K 0.06% 287
2024
Q4 		$841K Buy
+14,869
New +$831K 0.05% 324
2022
Q2 		– Sell
-13,127
Closed -$965K – 545
2022
Q1 		$965K Sell
13,127
-3,307
-20% -$222K 0.09% 193
2021
Q4 		$1.02M Sell
16,434
-3,092
-16% -$181K 0.12% 165
2021
Q3 		$1.17M Buy
19,526
+1,052
+6% +$69.3K 0.17% 136
2021
Q2 		$1.23M Buy
18,474
+1,090
+6% +$71.1K 0.18% 118
2021
Q1 		$1.11M Buy
17,384
+562
+3% +$35K 0.2% 98
2020
Q4 		$1.05M Buy
16,822
+114
+0.7% +$7.01K 0.23% 87
2020
Q3 		$1.01M Buy
16,708
+779
+5% +$46.9K 0.32% 68
2020
Q2 		$937K Sell
15,929
-32
-0.2% -$1.91K 0.36% 69
2020
Q1 		$890K Sell
15,961
-7,127
-31% -$436K 0.47% 56
2019
Q4 		$1.48M Buy
+23,088
New +$1.32M 0.6% 43
2017
Q3 		– Sell
-6,928
Closed -$386K – 195
2017
Q2 		$386K Buy
+6,928
New +$377K 0.12% 233

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

StoneX Group's BMY Position: Q1 2026 in Review

StoneX Group reduced its Bristol-Myers Squibb (BMY) stake by 43% in Q1 2026, selling an estimated $265K and leaving 5,915 shares worth $358K. The position accounts for 0.02% of the portfolio, ranked #512.

StoneX Group first reported a position in BMY in Q2 2017 and has held it in 17 quarters since. The position peaked at $1.48M in Q4 2019. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • StoneX Group held 5,915 shares of Bristol-Myers Squibb worth $358K as of Q1 2026.
  • StoneX Group sold 4,548 Bristol-Myers Squibb shares in Q1 2026, an estimated $265K.
  • Bristol-Myers Squibb made up 0.02% of StoneX Group's portfolio in Q1 2026, its #512 holding.
  • StoneX Group first reported a position in Bristol-Myers Squibb in Q2 2017 and has held it in 17 quarters since.
  • StoneX Group's Bristol-Myers Squibb position peaked at $1.48M in Q4 2019.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.